Safety Alerts & Recalls
What does this mean?
This recall for Advair HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you use an Advair HFA 45/21 inhaler and are concerned, you should speak to your pharmacist or doctor.
GlaxoSmithKline Recalls Several Lots of Advair HFA 45/21 Inhalers
GlaxoSmithKline has recalled select lots of Advair HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol. The following lot numbers have been recalled because these lots failed the routine stability tests performed by the manufacturer: 1ZP2465, 1ZP5224, 1ZP5455, 1ZP6916, 1ZP8042, 1ZP9593, 1ZP9900, 1ZP1134, 1ZP3190, 2ZP6531, 2ZP6924, 2ZP7258, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, 2ZP1331, and 2ZP2366.
Advair HFA contains the active ingredient fluticasone propionate and salmeterol and is commonly used in the treatment of asthma. This recall alert only applies to the select lots of Advair HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol. No other Advair HFA inhaler strengths or Advair Diskus products were involved in this recall.
To view the FDA notice about this recall, please visit: more information here